BioCentury
ARTICLE | Clinical News

Busulipo regulatory update

November 4, 2013 8:00 AM UTC

Pharmalink said FDA granted Orphan Drug designation for Busulipo, a liposome formulation of the generic chemotherapeutic busulfan, as a conditioning agent for use in cancer patients prior to hematopoi...